Venous Thromboembolism
Aspirin frequently used by patients on direct oral anticoagulants, tied to bleeding risk
Nearly one-third of patients with atrial fibrillation and/or venous thromboembolism treated with a direct oral anticoagulant, or DOAC, were also using aspirin without clear indications, researchers reported.
Revision TKR for infection, fracture doubles risk for venous thromboembolism
Compared with aseptic revision total knee replacement, revision for periprosthetic joint infection or fracture doubles the risk for postoperative venous thromboembolism, according to the published results.
Gender-affirming hormone therapy may increase VTE risk among transgender women
Gender‐affirming hormone therapy appeared to increase overall procoagulant profiles among transgender women but not transgender men, according to study results published in Journal of Thrombosis and Haemostasis.
COVID-19 confers elevated VTE risk in veterans
Among veterans hospitalized at Veterans Affairs facilities, patients with COVID-19 are at elevated risk for venous thromboembolism, according to a study published in the American Heart Journal.
Patients with COVID-19 at high risk for symptomatic VTE
Patients hospitalized with severe and non-severe COVID-19 appeared at increased risk for symptomatic venous thromboembolism, according to study results published in Journal of Thrombosis and Haemostasis.
What PCPs should know about VTE in patients with COVID-19
An increased incidence of venous thromboembolism, or VTE, among patients with COVID-19 has been observed since the early days of the pandemic.
No increased VTE risk with continued HT during gender-affirming surgery
Transgender and gender nonbinary patients who remain on estrogen hormone therapy during gender-affirming surgery do not have an increased risk for venous thromboembolism, according to findings published in The Journal of Clinical Endocrinology & Metabolism.
Therapeutic anticoagulation ups mortality risk among patients hospitalized with COVID-19
Patients hospitalized with COVID-19 who received high-dose therapeutic anticoagulation appeared to be at increased risk for mortality compared with those on prophylactic anticoagulation, according to a research letter in Thrombosis Research.
Low-dose aspirin led to low risk of VTE after shoulder arthroplasty
Use of low-dose aspirin yielded a low risk of venous thromboembolism and medication-associated complications after primary shoulder arthroplasty, according to results presented at the American Shoulder and Elbow Surgeons Annual Meeting.
Low-dose aspirin led to low risk of VTE after shoulder arthroplasty
Use of low-dose aspirin yielded a low risk of venous thromboembolism and medication-associated complications after primary shoulder arthroplasty, according to results presented at the American Shoulder and Elbow Surgeons Annual Meeting.